Acellular therapeutic agents for use in treating primary ovarian insufficiency (POI), polycystic ovary syndrome (PCOS), ovarian cancer, lung cancer, and breast cancer; Oncology therapeutic agents and diagnostics reagents for medical use; Extracellular vesicles diagnostic reagents for medical use and therapeutic agents for use in treating ovarian cancer, breast cancer, and lung cancer; Neurology diagnostic reagents for medical use and therapeutic agents for use in neurological treatments

Acellular Therapeutic agents for use in treating primary ovarian insufficiency (POI), Polycystic ovary syndrome (PCOS), ovarian cancer, lung cancer, and breast cancer; Oncology Therapeutic agents and Diagnostics reagents for medical use; Extracellular Vesicles diagnostic reagents for medical use and Therapeutic agents for use in treating ovarian cancer, breast cancer, and lung cancer; Neurology Diagnostic reagents for medical use and Therapeutic agents for use in neurological treatments

Acellular therapeutic agents for use in treating primary ovarian insufficiency (POI), polycystic ovary syndrome (PCOS), ovarian cancer, lung cancer, and breast cancer; Oncology therapeutic agents and diagnostics reagents for medical use; Extracellular vesicles diagnostic reagents for medical use and therapeutic agents for use in treating ovarian cancer, breast cancer, and lung cancer; Neurology diagnostic reagents for medical use and therapeutic agents for use in neurological treatments